Claire McKeague

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Age-related macular degeneration (AMD) is the leading cause of blindness among older adults in the developed world. The only treatments currently available, such as ranibizumab injections, are for neovascular AMD, which accounts for only 10 to 15% of people with the condition. Hypoxia has been implicated as one of the primary causes of AMD, and(More)
PURPOSE To evaluate the intersession repeatability of the Colour Assessment and Diagnosis (CAD) test and a novel 14-Hz flicker test in a population of healthy participants to provide benchmark data for their use as functional biomarkers for age-related macular degeneration (AMD). METHODS Visual function was assessed using both techniques in 30 healthy(More)
  • 1